Poster Abstract Session:
239. HIV and Viral Hepatitis Co-Infection
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, HIV-STD-TB, Pediatric ID


Presentations:
2231
Long-term Immunogenicity of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: An extension of a randomized controlled trial
Romanee Chaiwarith, MD; Jutarat Praparattanapan, PhD; Jiraprapa Wipasa, PhD; Kanokporn Chaiklang, MD; Khuanchai Supparatpinyo, MD
Posters
  • Poster number 2231_chaiwarith.pdf (765.1 kB)
    • 2232
    Zinc deficiency and advanced liver fibrosis among HIV/HCV co-infected persons in Russia
    Joshua Barocas, MD; Kaku So-Armah, PhD; Debbie Cheng, PhD; Dmitry Lioznov, MD; Marianna Baum, PhD, MS; Kerrin Gallagher, MS; Daniel Fuster, MD; Natalia Gnatienko, MS; Evgeny Krupitsky, MD; Matthew Freiberg, MD, MSc; Jeffrey Samet, MD, MPH
    Posters
  • Barocas_IDWeek_poster.pdf (500.2 kB)
    • 2233
    Hepatitis C Eradication: Who is being left behind in the HIV population?
    Mamta K Jain, MD, MPH; Claudia Chavez, B.S.; Joanne Sanders, MS; Kranthi Vysyaraju, MS
    Posters
  • IDSA Poster 2018 HCV Eradicate.pdf (480.2 kB)
    • 2234
    Implementing a Co-located HCV Clinic within an HIV Clinic: Four Year Experience
    Merceditas Villanueva, MD; Christina Rizk, MSc.; Bethel Shiferaw, MD; Onyema Ogbuagu, MD, FACP; Maricar Malinis, MD, FACP, FIDSA; Janet Miceli, MPH
    Posters
  • HCV care model_POSTER IDWEEK2018 FINAL 9.26.2018[1].pdf (351.0 kB)
    • 2235
    A Collaborative Drug Therapy Management Model for the Treatment of Hepatitis C Virus (HCV) in an Urban Clinic
    Sonia Vibhakar, PharmD; Diana Nowicki, PharmD; Greg Huhn, MD; Rebecca Goldberg, RN; Oluwatoyin Adeyemi, MD
    2236
    Direct-Acting Antivirals: Efficacy in a Real-World, Urban, Undeserved, HIV-HCV Co-Infected Population
    Sarah Michienzi, PharmD, BCPS, AAHIVP; Rodrigo Burgos, PharmD, AAHIVP; Renata Smith, PharmD, AAHIVP; Michelle Martin, PharmD, PharmD, FCCP, BCPS, BCACP
    Posters
  • ID Week 2018 HIV-HCV Poster FINAL Corrected.pdf (196.9 kB)
    • 2237
    Validity of Self-Reported HCV Status among Justice-Involved Persons Living with HIV
    Amanda Noska, MD, MPH; Tao Liu, MS; Irene Kuo, PhD, MPH; Mia Coetzer, PhD; Ann Kurth, PhD, MPH; Rami Kantor, MD; Curt Beckwith, MD
    Posters
  • Noska_SelfReportValidityHCVStatus_IDWeek2018_Final.pdf (708.5 kB)
    • 2238
    Immunogenicity and safety of 4- vs. 3-standard doses HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
    Nattinee Laksananun, MD; Romanee Chaiwarith, MD
    Posters
  • NattineeL-RC-2238.pdf (701.4 kB)

    • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.